Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Albertsons $750 million accelerated share repurchase
We advised Albertsons on the transaction
IREN $1 billion convertible notes offering
We advised IREN on the offering
Comcast $1.17 billion exchange offers and $754.69 million cash tender offers
We advised Comcast on the concurrent exchange and cash tender offers
Turn Therapeutics direct listing
We advised Turn Therapeutics on its Nasdaq listing
CoreWeave acquisition of Monolith AI
We are advising CoreWeave on the transaction
Credo Technology $750 million at-the-market offering
We advised Credo on the offering
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
Oruka Therapeutics $200 million at-the-market offering
We advised Oruka on the offering
Emera $750 million fixed-to-fixed reset rate junior subordinated notes offering
We advised Emera on its offering
Arcos Dorados $200 million revolving credit facility
We advised Arcos Dorados on the transaction